The association between inflammation, arterial stiffness, oxidized LDL and cardiovascular disease in Finnish men with metabolic syndrome – a 15-year follow-up study

[1] Lakka HM(2002)The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men J Am Med Assoc 288 2709-16

[2] Laaksonen DE(2003)Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 987-1003

[3] Lakka TA(2016)Predicting Coronary Heart Disease and Stroke: the FINRISK calculator Glob Heart 11 213-6

[4] Niskanen LK(1997)Inflammation, aspirin, and the risk of Cardiovascular Disease in apparently healthy men N Engl J Med 336 973-9

[5] Kumpusalo E(2012)Role of arterial stiffness in cardiovascular disease JRSM Cardiovasc Dis 1 1-10

[6] Tuomilehto J(1994)Aortic compliance measurements: a non-invasive indicator of atherosclerosis? Lancet 343 1447-6

[7] Conroy R(1997)Low density lipoprotein oxidation and its pathobiological significance J Biol Chem 272 20963-12

[8] Vartiainen E(2012)Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models Ann Med 44 503-97

[9] Laatikainen T(2001)Evaluation, and treatment of high blood cholesterol in adults E and T of HBC in A. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA: J Am Med Association 285 2486-93

[10] Peltonen M(2008)Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome JAMA 299 2287-19

[1] Lakka HM(2002)The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men J Am Med Assoc 288 2709-16

[2] Laaksonen DE(2003)Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 987-1003

[3] Lakka TA(2016)Predicting Coronary Heart Disease and Stroke: the FINRISK calculator Glob Heart 11 213-6

[4] Niskanen LK(1997)Inflammation, aspirin, and the risk of Cardiovascular Disease in apparently healthy men N Engl J Med 336 973-9

[5] Kumpusalo E(2012)Role of arterial stiffness in cardiovascular disease JRSM Cardiovasc Dis 1 1-10

[6] Tuomilehto J(1994)Aortic compliance measurements: a non-invasive indicator of atherosclerosis? Lancet 343 1447-6

[7] Conroy R(1997)Low density lipoprotein oxidation and its pathobiological significance J Biol Chem 272 20963-12

[8] Vartiainen E(2012)Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models Ann Med 44 503-97

[9] Laatikainen T(2001)Evaluation, and treatment of high blood cholesterol in adults E and T of HBC in A. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA: J Am Med Association 285 2486-93

[10] Peltonen M(2008)Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome JAMA 299 2287-19